Outcomes of Adults Treated with a Hypomethylating Agent Plus Venetoclax for Relapsed/Refractory Acute Myeloid Leukemia: A Multicenter Retrospective Study
Blood | November 28, 2022 | Volume: 140 | Issue: Supplement 1 | Pages: 6187-6188
10.1182/blood-2022-170647